Last reviewed · How we verify
NCT07530783
Defining Retinal and Choroidal Structures Using Hyperspectral Imaging
NA trial testing Hyperspectral retinal imaging in Retinal Disease in 679 participants. Terminated before completion.
21 January 2025
Quick facts
| Lead sponsor | Center for Eye Research Australia |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 679 |
| Start date | 25 February 2016 |
| Primary completion | 21 January 2025 |
| Estimated completion | 21 January 2025 |
Drugs / interventions tested
- Hyperspectral retinal imaging
Conditions studied
- Retinal Disease — all drugs for Retinal Disease →
Sponsor
Center for Eye Research Australia
Who can join
18 and older, any sex, with Retinal Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates a novel, non-invasive imaging technique called hyperspectral retinal imaging to improve the identification and characterisation of retinal and choroidal structures in both healthy and diseased eyes. Hyperspectral imaging captures retinal images across multiple wavelengths of light, generating detailed spectral information that may reveal biological and structural features not visible with conventional retinal photography. Approximately 1000 participants will undergo retinal imaging at specialist eye clinics in Melbourne, Australia. The study aims to determine whether hyperspectral imaging can detect spectral signatures associated with retinal and optic nerve diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration, and whether these signatures correlate with disease severity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07530783
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Retinal Disease
Currently open trials in the same condition.
- NCT07149740 — Data Gathering for A10900 · recruiting
- NCT06852963 — A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Parti · Phase 1, PHASE2 · recruiting
- NCT05699096 — Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anterior · recruiting
- NCT06289452 — Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis · EARLY_PHASE1 · active not recruiting
- NCT06520410 — Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries · Phase 4 · recruiting
Other Center for Eye Research Australia trials
Trials by the same sponsor.
- NCT06587945 — Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment · Phase 4 · recruiting
- NCT06908161 — Functional Assessments in Vision Impairment · not yet recruiting
- NCT05200624 — Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study · NA · terminated
- NCT05158049 — Longitudinal Study of a Bionic Eye · enrolling by invitation
- NCT03105609 — Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07530783 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Center for Eye Research Australia
- Last refreshed: 15 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07530783.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing